While in a randomized study of advanced melanoma patients treated with T-VEC, patients with mutant BRAF occurred CR in 5 (10.9%) and PR in 9 (19.6%) patients, and patients with wild-type BRAF occurred CR in 5 (11.1%) and PR in 9 (20.0%) patients [36]. Here, BRAF is linked to melanoma.